Incentives given to substitutive dispensing for drugs proven of their bio-equivalency.

The Health Insurance Review Agency (HIRA) reported to the National Assembly on June 20 that a certain rate of incentives be given to pharmacists when dispensing expensive drugs for a low priced substitutive drugs proven of bio-equivalency in order to restrict expensive drug prescriptions, and the reference price system should be launched from coming August initially applying to the anti-pyretic...